There are an estimated > 400 million people living with a rare disease globally, with genetic variants the cause of approximately 80% of cases. Next…
Over 400 million people worldwide are living with a rare disease. Next Generation Sequencing identifies potential disease causative genetic variants.…
Cancer vaccination drives the generation of anti-tumor T cell immunity and can be enhanced by the inclusion of effective immune adjuvants such as typ…
The research of the Translational Genetics team is focussed on providing molecular analysis of genetic variants (gene mutations), to better inform th…